CEO of Protenus, leveraging AI to reduce risk and improve patient trust for healthcare systems across North America.
The global cataclysm of Covid-19 continues to take its toll in ways none of us could have imagined at the start of 2020. Some researchers predict that its economic effects will last for decades. By then, with hindsight, we might understand the true effect the pandemic has had. For now, we can only experience the absolute disruption to our everyday lives created by Covid-19 and strive for the innovation required to respond to it.
In business, people talk about “disruptive innovation,” which is actually quite elusive because the term describes when a new idea comes along and completely undoes an existing market like the effect Netflix had on video stores or Amazon had on retail.
Covid-19 is a truly disruptive force, driving innovation and accelerating change in industries that are
The novel coronavirus pandemic has fundamentally changed doctor-patient dynamics worldwide. On one hand, healthcare workers and doctors are tirelessly working to treat COVID patients, while on the other, elderly patients and those with chronic diseases who need routine medical check-ups are faced with increased vulnerability and the risk of contracting coronavirus during regular hospital visits. While all of this is going on, patients with milder symptoms are being encouraged to use telehealth platforms to alleviate the strain on hospital facilities. A part of the solution to all these problems is one word: telemedicine.
Here’s a look at what telemedicine is, and how Nvidia (NVDA) is supporting it as the broader digital health ecosystem.
Telemedicine is a term that was coined in the 1970s, and the WHO currently defines it as the “delivery of health care services, where patients and providers are separated by distance. Telehealth uses information and communication